A significant trend for increasing Z‐4OHtam concentrations and improved BCSS was identified for the ‘tamoxifen‐only’ subgroup ( P ‐trend = 0.048; Fig. 4C ).
← all excerpts
Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen.
1
—
—